264 related articles for article (PubMed ID: 24816477)
1. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
[TBL] [Abstract][Full Text] [Related]
2. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.
Urs R; Potter E; Barker W; Appel J; Loewenstein DA; Zhao W; Duara R
J Comput Assist Tomogr; 2009; 33(1):73-8. PubMed ID: 19188789
[TBL] [Abstract][Full Text] [Related]
3. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
4. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.
Shen Q; Loewenstein DA; Potter E; Zhao W; Appel J; Greig MT; Raj A; Acevedo A; Schofield E; Barker W; Wu Y; Potter H; Duara R
Alzheimers Dement; 2011 Jul; 7(4):e101-8. PubMed ID: 21784342
[TBL] [Abstract][Full Text] [Related]
5. The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects.
Duara R; Loewenstein DA; Shen Q; Barker W; Varon D; Greig MT; Curiel R; Agron J; Santos I; Potter H
Front Aging Neurosci; 2013; 5():47. PubMed ID: 24065917
[TBL] [Abstract][Full Text] [Related]
6. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.
Du AT; Schuff N; Amend D; Laakso MP; Hsu YY; Jagust WJ; Yaffe K; Kramer JH; Reed B; Norman D; Chui HC; Weiner MW
J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):441-7. PubMed ID: 11561025
[TBL] [Abstract][Full Text] [Related]
8. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
[TBL] [Abstract][Full Text] [Related]
9. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
Pennanen C; Kivipelto M; Tuomainen S; Hartikainen P; Hänninen T; Laakso MP; Hallikainen M; Vanhanen M; Nissinen A; Helkala EL; Vainio P; Vanninen R; Partanen K; Soininen H
Neurobiol Aging; 2004 Mar; 25(3):303-10. PubMed ID: 15123335
[TBL] [Abstract][Full Text] [Related]
10. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
[TBL] [Abstract][Full Text] [Related]
11. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
[TBL] [Abstract][Full Text] [Related]
12. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
13. Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment.
Varon D; Loewenstein DA; Potter E; Greig MT; Agron J; Shen Q; Zhao W; Celeste Ramirez M; Santos I; Barker W; Potter H; Duara R
Dement Geriatr Cogn Disord; 2011; 31(4):276-83. PubMed ID: 21494034
[TBL] [Abstract][Full Text] [Related]
14. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
15. Higher atrophy rate of entorhinal cortex than hippocampus in AD.
Du AT; Schuff N; Kramer JH; Ganzer S; Zhu XP; Jagust WJ; Miller BL; Reed BR; Mungas D; Yaffe K; Chui HC; Weiner MW
Neurology; 2004 Feb; 62(3):422-7. PubMed ID: 14872024
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
17. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
[TBL] [Abstract][Full Text] [Related]
18. Atrophy rates of entorhinal cortex in AD and normal aging.
Du AT; Schuff N; Zhu XP; Jagust WJ; Miller BL; Reed BR; Kramer JH; Mungas D; Yaffe K; Chui HC; Weiner MW
Neurology; 2003 Feb; 60(3):481-6. PubMed ID: 12578931
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
Chetelat G; Baron JC
Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
